Market Access
For a more in-depth look at market access trends and timelines comparing 2021 data to that of the past four years, order MORSE Consulting’s Canadian Reimbursement and Forecasting Timelines (CRaFT) report. Click on graphic to print or see full-size OR download PDF. Please contact info@morseconsulting.ca regarding any questions on this infographic or on the CRaFT report. Embed this infographic (copy and paste code) on your website with attribution: <p><a href="https://morseconsulting.ca/morse-consulting-releases-its-pcpa-quarterly-update-q4-2022"><img…
MORSE has been providing monthly data analytics and expert insights through our pCPA updates since 2017. Starting in 2022, MORSE is now publishing the pCPA updates on a quarterly basis. For a more in-depth look at market access trends and timelines comparing 2021 data to that of the past four years, order MORSE Consulting’s Canadian Reimbursement and Forecasting Timelines (CRaFT) report. Click on graphic to print or see full-size…
MORSE has been providing monthly data analytics and expert insights through our pCPA updates since 2017. Starting in 2022, MORSE is now publishing the pCPA updates on a quarterly basis. Last quarter, Keytruda initiated and completed pCPA negotiations 2022-02-11. This was not captured in our previous update, but has since been accounted for in our dataset and the infographic below. For a more in-depth look at market access trends and…
MORSE has been providing data analytics and expert insights through our pCPA updates on a monthly basis since 2017. Starting in 2022, MORSE will be publishing the pCPA updates quarterly instead of monthly. We extend our gratitude to those who provided feedback in anticipation for the transition to a quarterly update. We are pleased to release our first Quarterly pCPA Update Infographic. This resource is aimed at helping market access…
Recently announced changes to CADTH’s Reimbursement Review submission requirements, effective October 2022 necessitates completion of the Sponsor Summary of Clinical Evidence template. The new clinical evidence template is comprehensive, including but not limited to: background information on the clinical condition, current treatment paradigm, unmet need, and place in therapy methods and findings of a systematic literature search for clinical trials of the drug under review summary of evidence from other…
MORSE Consulting is pleased to release our Fifth Annual pCPA Year in Review Infographic – 2021 Edition. This resource is aimed at helping market access stakeholders understand the top-line pCPA highlights from 2021. This infographic compares year-over-year metrics including: pCPA activity summary; addresses backlog of files under consideration; average time to complete a negotiation; and files adjudicated by the pCPA by type. MORSE Consulting’s Canadian Reimbursement and Forecasting Timelines (CRaFT)…
Author: Patrick Manfred, Vice-President, TACT Conseil, Quebec Market Access Expert Date: June 2, 2021 A proposal to modify the current regulation framing the fees payable to the Institut national d'excellence en santé (INESSS) to complete a scientific evaluation of a drug and/or a stable blood product was published in Part 2 of the Quebec Official Gazette, on March 18, 2021. If the Quebec government does not deviate from…
MORSE Consulting is pleased to release our Fourth Annual pCPA Year in Review Infographic – 2020 Edition. This resource is aimed at helping market access stakeholders understand the top-line pCPA highlights from 2020. This infographic compares year-over-year metrics including: pCPA activity summary; the effect of COVID-19 on under-consideration files; average time to complete a negotiation; and files adjudicated by the pCPA by type in 2020. This infographic is an excerpt…
MORSE Consulting is pleased to release our Third Annual pCPA Year in Review infographic - 2019 Edition. This resource is aimed at helping market access stakeholders understand the top-line pCPA highlights from 2019. This infographic compares year-over-year metrics including: pCPA activity summary; average time to complete a negotiation; files adjudicated by the pCPA; and average negotiation duration by source. This infographic is an excerpt from the 2019 update of MORSE Consulting’s Canadian Reimbursement Trends…
Mani & O’Quinn Reimbursement Strategy Experts (MORSE) Consulting Inc. is pleased to introduce MORSE WIRE, a new feature on our website. MORSE WIRE is a newsfeed that provides real time, useful market access information to help stakeholders stay informed of the latest developments in the Canadian pharmaceutical reimbursement environment. MORSE WIRE has a user-friendly interface with 5 broad categories to allow users to sort and search based on keywords. The…
MORSE Consulting Inc. | Deciphering Canadian pharmaceutical market access signals to create reimbursement success.
© 2023 MORSE Consulting Inc. All rights reserved. |
Site by Directica Media
Market Access - Info and details on - MORSE Consulting Inc.